34th Annual ECCMID
28 April 2024 • Barcelona, Spain | |
|
Updates in cytomegalovirus and serious Gram-negative infections: Striving for better outcomes |
|
|
|
|
|
Featured faculty
|
| Andre Kalil |
ESCMID appointed chair
University of Nebraska
Medical Center
|
| Omaha, Nebraska, USA |
|
| Roy Chemaly |
Chair
MD Anderson Cancer Center
|
| Houston, Texas, USA |
|
| Souha Kanj |
Chair
American University of
Beirut Medical Center
|
| Beirut, Lebanon |
|
| Genovefa Papanicolaou |
Memorial Sloan Kettering
Cancer Center
Weill Cornell Medical College
|
| New York, New York, USA |
|
| Klemens Budde |
Charite University
|
| Berlin, Germany |
|
| Ryan Shields |
University of Pittsburgh
Medical Center
|
| Pittsburgh, Pennsylvania, USA |
|
| Sundeep Kaul |
Harefield Hospital
|
| Uxbridge, UK |
|
|
|
Symposium sponsored by MSD
Sunday, 28 April 2024
13:30 - 15:30 (CEST)
|
Agenda
|
Details
|
Speaker
|
|
13:30 – 13:33
|
Welcome and introduction |
Andre Kalil, Roy Chemaly |
|
13:33 – 14:31 |
Part 1: Advancements in CMV management:
Examining past, present, and future strategies in HSCT
and solid organ transplantation |
|
13:33 – 13:35
|
Opening remarks
|
Roy Chemaly
|
|
13:35 – 13:53
|
CMV prophylaxis in HSCT: Past, present, and future
|
Genovefa Papanicolaou
|
|
13:53 – 14:11
|
New frontiers in CMV prophylaxis in solid organ transplantation: State of the art update
|
Klemens Budde
|
|
14:11 – 14:31
|
Panel discussion and Q&A |
All with moderators: Roy Chemaly and Andre Kalil
|
|
14:31 – 15:29 |
Part 2: Emerging strategies in the management of nosocomial pneumonia in critically ill patients: Addressing the challenge of MDR pathogens
|
|
14:31 – 14:33
|
Opening remarks
|
Souha Kanj
|
|
14:33 – 14:51
|
Unraveling the evolving landscape of resistance: Recent updates and novel findings
|
Ryan Shields
|
|
14:51 – 15:09
|
Unveiling real-world evidence: Lessons learned from managing patients failing initial antibacterial therapy
|
Sundeep Kaul
|
|
15:09 – 15:29
|
Panel discussion and Q&A |
All with moderators: Souha Kanj and Andre Kalil
|
|
15:29 – 15:30
|
Closing remarks |
Andre Kalil, Souha Kanj
|
|
|
Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
All rights reserved. HQ-NON-00891 04/24 -5347444-2
|
|
|
|